trending Market Intelligence /marketintelligence/en/news-insights/trending/z3sddh1UZmdlpmN1dSbdgA2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Gemphire CEO resigns; interim replacement named

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Gemphire CEO resigns; interim replacement named

Mina Sooch resigned as president, CEO and director of Gemphire Therapeutics Inc. due to personal reasons, effective May 23.

Steven Gullans, a board member since April 2016, has been named interim president and CEO until a search for a replacement is completed.

Gullans is a managing director at venture capital firm Excel Venture Management LLC, which owns more than 5% of Gemphire's outstanding common stock.